Ataxia associated with Hashimoto's disease: Progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 1, 2001, Pages 81-87

  Selim, M ^a   Drachman, D A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Ataxia; Autoimmune; Cerebellar degeneration; Hashimoto's autoimmune thyroiditis

Indexed keywords

ADULT; ARTICLE; ATAXIA; CEREBELLUM DEGENERATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HASHIMOTO DISEASE; HUMAN; IMMUNOMODULATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL;

AGED; ATAXIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SPINOCEREBELLAR DEGENERATIONS; THYROIDITIS, AUTOIMMUNE;

EID: 0034962856     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.1.81     Document Type: Article

References (46)

1. Mancall EL, McEntee WJ. Alterations of the cerebellar cortex in nutritional encephalopathy. Neurology 1965;15:303-13.
2. Victor M, Adams R, Mancall EL. A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch Neurol 1959;1:579-88.
3. Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997;120:1279-300.
4. Déjerine J, Thomas A. L'atrophie olivo-ponto-cerebelleuse. Nouvelle Icongraphy de la Salpétriére 1900;13:330.
5. Barnard R, Campbell M, McDonald W. Pathological findings in a case of hypothyroidism with ataxia. J Neurol Neurosurg Psychiatry 1971;34:755-60.
6. Bonuccelli U, Nuti A, Monzani F, et al. Familial occurrence of hypothyroidism and cerebellar ataxia. Funct Neurol 1991; 6:171-5.
7. Cremer GM, Goldstein NP, Paris J. Myxedema and ataxia. Neurology 1969;19:37-46.
8. Erkulvrawatr S. Gait ataxia in hypothyroidism. J Ky Med Assoc 1977;75:581-2.
9. Gentilini M, Palmieri M. Myxedematous cerebellar ataxia: description of a case. Rivista di Patologica Nervosae Mentale 1984;105:75-80.
10. Hammar CH, Regli F. Cerebellar ataxia due to hypothyroidism in adults. Dtsch Med Wochenschr 1975;100:1504-6.
11. Jellinek EH, Kelly RE. Cerebellar syndrome in myxoedema. Lancet 1960;2:225-7.
12. Söderbergh G. Encore un cas de myxoedeme avec symptomes cerebelleux. Rev Neurol (Paris) 1911;22:86-9.
13. Somalwar A, Jalgaonkar P. Bilateral cerebellar syndrome in a case of myxoedema. J Indian Med Assoc 1996;94:241.
14. Takayanagi K, Satoth A, Yoshimura T, et al. A case of myxoedema associated with cerebellar ataxia and various neurological findings. Nippon Naika Gakkai Zasshi 1982;71:995-8.
15. Wiebel J. Cerebellar-ataxic syndrome in children and adolescents with hypothyroidism under treatment. Acta Paediatr Scand 1976;65:201-5.
16. Saiz A, Arpa J, Sagasta A, et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997;49:1026-30.
17. Chiu A, Sherman S. Clinical manifestations and differential diagnosis of hypothyroidism. In: Falk SA, ed. Thyroid disease: endocrinology, surgery, nuclear medicine, and radiotherapy. 2nd ed. Philadelphia: Lippincott-Raven, 1997: 379-1.
18. Adams R, Victor M, Ropper A. Principles of neurology. 6th ed. New York: McGraw-Hill, 1997:1084-6.
19. Dalmau JO, Posner JB. Paraneoplastic syndromes. Arch Neurol 1999;56:495-8.
20. Dropcho EJ. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Ann Neurol 1995;37(suppl 1):S102-13.
21. Porta-Etessam J, Berbel A, Martinez-Salio A, et al. Paraneoplastic cerebellar degeneration with symmetrical pancerebellar syndrome. Rev Neurol 1998;26:1015-17.
22. Roy M, Stip E, Black D, et al. Cerebellar degeneration following acute lithium intoxication. Rev Neurol (Paris) 1998;154:546-8.
23. Holmes GM. A form of familial degeneration of the cerebellum. Brain 1907;30:466.
24. Honnorat J, Trouillas P, Thivolet C, et al. Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol 1995; 52:462-8.
25. Tanaka M, Kawarabayashi T, Okamoto K, et al. Reduction of cerebral blood flow and metabolic rate of oxygen in a case of hypothyroidism presenting with cerebellar ataxia. Rinsho shinkeigaku 1987;27:1262-5.
26. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Eng J Med 1996;335:99-107.
27. Wyngaarden J, Lloyd S. Cecil textbook of medicine. 17th ed. Philadelphia: WB Saunders, 1985:1275-99.
28. Dropcho EJ. Neurologic paraneoplastic syndromes. J Neurol Sci 1998;153:264-78.
29. Manto M, Rondeaux P, Jacquy J, et al. Subacute pancerebellar syndrome associated with systemic lupus erythromatosus. Clin Neurol Neurosurg 1996;98:157-60.
30. Price TR, Netsky MG. Myxedema and ataxia; cerebellar alterations and neural myxedema bodies. Neurology 1966; 16:957-62.
31. Uyematsu S. A case of myxedematous psychosis: clinical and pathological report. Arch Neurol Psychiatry 1920;3: 252-76.
32. Pinchera A, Fenzi G, Chiovato L, et al. Autoimmune hypothyroidism. In: Drexhage HA, Wiersinga WM, eds. The thyroid and autoimmunity. New York: Elsevier, 1986;73-8.
33. Becker KL, Ferguson RH, McConahey WM. The connective tissue diseases and symptoms associated with Hashimoto's thyroiditis. N Engl J Med 1963;268:277-80.
34. Pryse-Phillips W. The epidemiology of multiple sclerosis. In: Cook SD, ed. Handbook of multiple sclerosis, 2nd ed. New York: M Dekker, 1996:1-17.
35. Bednarczuk T, Kennerdell J, Wall J. Thyroid-associated ophthalmopathy: etiology and pathogenesis. In: Falk SA, ed. Thyroid disease: endocrinology, surgery, nuclear medicine, and radiotherapy. 2nd ed. Philadelphia: Lippincott-Raven, 1997:341-57.
36. Cohen L, Mouly S, Tassan P, et al. A woman with a relapsing psychosis who got better with prednisone. Lancet 1996; 347:1228.
37. Concetta M. Forchetti, G. Katsamakis, et al. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology 1997;49:623-6.
38. Shaw PJ, Walls TJ, Newman PK, et al. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers: report of five cases. Neurology 1991;41:228-33.
39. Shein M, Apter A, Dickerman Z, et al. Encephalopathy in compensated Hashimoto's thyroiditis: a clinical expression of autoimmune cerebral vasculitis. Brain Dev 1986;8:60-4.
40. Nickel SN, Frame B. Neurologic manifestations of myxedema. Neurology 1958;8:511-17.
41. McGeer PL, McGeer EG. Amino acid neurotransmitters. In: Siegel G, Agranoff B, Albers RW, eds. Basic neurocheinistry: molecular, cellular, and medical aspects. 4th ed. New York: Raven, 1989:311-32.
42. Gilman S, Bloedel J, Lechtenberg R. Disorders of the cerebellum. Philadelphia: FA Davis, 1981:244-50.
43. Grimaldi L, Quattrini A, Martino G. Cerebellar autoantibodies in patients with isolated or associated stiff-man syndrome and cerebellar atrophies. Neurology 1990;40(suppl 1):117-18.
44. Nemni R, Bonifacio E, Mortara A, et al. Characterization and quantification of autoantibodies to glutamic acid decarboxylase in neurological syndromes. J. Neurol 1996; 243(suppl 2):S23.
45. Zuchenko O, Bailey J, Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α 1A-voltage-dependent calcium channel. Nature Genetics 1997;15:62-9.
46. Voltz R, Carpentier AF, Rosenfield MR, et al. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system. Muscle Nerve 1999;22:119-22.